Cytomegalovirus reactivation under pre-emptive therapy following allogeneic hematopoietic stem cell transplant: Pattern, survival, and risk factors in the Republic of Korea.

<h4>Introduction</h4>Pre-emptive therapy for cytomegalovirus (CMV) reactivation has been used in allogeneic hematopoietic stem cell transplantation (allo-HSCT). It is unclear if this strategy has poorer clinical outcomes in CMV-endemic areas and if more aggressive prophylaxis is required...

Full description

Bibliographic Details
Published in:PLoS ONE
Main Authors: Ka-Won Kang, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Byung-Hyun Lee, Se Ryeon Lee, Chul Won Choi, Yong Park, Byung Soo Kim, Hwa Jung Sung
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0291268&type=printable